Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin

被引：24
|
作者：
de Zwaan, Sally E. [3 ]
Iland, Harry J. [1 ]
Damian, Diona L. [2 ,3 ]
机构：
[1] Royal Prince Alfred Hosp, Dept Haematol, Sydney, NSW, Australia
[2] Univ Sydney, Dept Dermatol, Sydney, NSW 2006, Australia
[3] Royal Prince Alfred Hosp, Dept Dermatol, Sydney, NSW, Australia
来源：
AUSTRALASIAN JOURNAL OF DERMATOLOGY | 2009年 / 50卷 / 01期
关键词：
corticosteroid adverse effects; diabetes mellitus; imatinib mesylate;
D O I：
10.1111/j.1440-0960.2008.00506.x
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
We report a patient with pyoderma gangrenosum successfully treated with intravenous immunoglobulin. He had previously been treated for 4 years with high-dose corticosteroids and had developed insulin-dependent diabetes mellitus. Multiple corticosteroid-sparing agents had failed or were contraindicated. He developed no adverse effects from intravenous immunoglobulin, which allowed reduction of his prednisone to 3 mg/day, and his ulcer has completely healed.
引用
收藏
页码：56 / 59
页数：4
相关论文
共 50 条
12345